AGT and cardiac hypertrophy: In our current study, CYP2J2 overexpression significantly prevented Ang II‐induced cardiac hypertrophy, and therefore, we speculated CYP2J2 may have important protective effects against aging‐induced cardiac hypertrophy and consequential heart failure.